Searched for
SENORES PHARMACEUTICALS IPO
Senores Pharma shares in focus after deal to acquire USFDA-approved epilepsy drug from WockhardtSenores Pharmaceuticals is set to acquire Wockhardt's USFDA-approved ANDA for Topiramate tablets, a medication used for epilepsy and migrai...- Senores Pharma to acquire 14 ANDAs from Dr Reddy's LaboratoriesSenores Pharmaceuticals of Gujarat has signed an agreement to acquire 14 Abbreviated New Drug Applications from Dr Reddy's Laboratories. Th...
- Kothari Products announces 1:1 bonus share issue, stock up 7%Kothari Products announced a 1:1 bonus share issue, causing a 7.4% stock rise to Rs 209.70. The issuance will be financed from free reserve...
- JSW Energy shares zoom nearly 8% on signing Rs 12,468 cr definitive agreement with O2 PowerJSW Energy Share Price: Shares of JSW Energy rose 7.7% as its subsidiary JSW Neo Energy signed a definitive agreement to acquire O2 Power's...
- Utkarsh Small Finance Bank shares jump 4% after approving sale of NPAs worth Rs 355 croreUtkarsh Small Finance Bank plans to sell its non-performing assets and written-off loans to an asset reconstruction company. The loans amou...
- IL&FS Engineering shares jump 5% after securing Rs 303 crore Bhubaneswar Metro projectIL&FS Engineering and Construction has been awarded a Rs 302.82 crore project from Ceigall India for the Bhubaneswar Metro Phase-I. The pro...
- Senores Pharma shares list at 53% premium over IPO priceSenores Pharmaceuticals’ shares debuted with over a 50% premium on Indian exchanges, reflecting a robust investor response to the IPO, whic...
- Ola Electric shares slide 5% after CTO and CMO resign amid leadership exodusOla Electric share price: Shares of Ola Electric dropped 4.6% amid the resignation of senior executives Suvonil Chatterjee and Anshul Khand...
- Vodafone Idea shares in focus after Vodafone Group clears Rs 11,650 crore dues secured against VIL sharesVodafone Idea share price: Vodafone Group has cleared Rs 11,650 crore in outstanding dues related to its stake in Vodafone Idea. The paymen...
- Reliance Industries shares in focus after acquiring Karkinos Healthcare for Rs 375 croreReliance Industries share price: Reliance Industries acquired Karkinos Healthcare for Rs 375 crore through its subsidiary Reliance Strategi...
- Senores Pharmaceuticals IPO: Check allotment status, GMP, listing date and other detailsSenores Pharmaceuticals IPO share allotment will be finalized soon, with investors able to check their status via BSE or the registrar's we...
- Senores Pharma IPO subscribed 93.41 times on Day 3. Check GMP, listing date and other key detailsSenores Pharma's IPO subscription was oversubscribed at 93.41 times driven by retail, non-institutional, and qualified institutional buyers...
- Senores Pharma IPO subscribed 13.88 times on Day 2. Check GMP, key dates, price bandRetail investors subscribed to the issue 38.34 times, while non-institutional investors (NIIs) subscribed 24.48 times. Qualified institutio...
- Senores Pharma IPO subscribed 1.8 times on Day 1: Check key dates, price band, GMP and reviewSenores Pharmaceuticals' IPO received 1.8 times subscription on its opening day, driven primarily by retail investors, who oversubscribed b...
- Senores Pharma has niche positives, can be a long-term betIncorporated in 2017, the company identifies, develops and commercialises speciality and complex niche products in mid-market range. It als...
- Senores Pharmaceuticals collects Rs 261 cr from anchor investorsSenores Pharmaceuticals Ltd on Thursday said it has secured nearly Rs 261 crore from anchor investors, ahead of its initial share-sale open...
- Senores Pharmaceuticals sets price band at Rs 372-391 for Rs 582 crore IPO. Check detailsAhmedabad-based Senores Pharmaceuticals is set to launch its IPO on December 20, with a price band of Rs 372-391. The issue includes a fres...
- Senores Pharmaceuticals IPO to open for bidding on December 20. Check detailsSenores Pharmaceuticals is launching its IPO on December 20. The issue comprises a fresh issue of Rs 500 crore and an OFS of 21 lakh shares...
- Sebi green lights issues of Sagility, Senores PharmaWhen a company receives a final observation from Sebi, it’s a signal from the regulator to go ahead with the IPO process.
- Senores Pharmaceuticals files DRHP for IPO. Check detailsUnder the OFS, up to 8.5 lakh equity shares by Swapnil Jatinbhai Shah, up to 5.5 lakh equity shares by Ashokkumar Vijaysinh Barot, up to 3 ...
Load More
